-

Northwell Health’s Constellation Forum 2024: Navigating Health Care in an Age of AI, Digital Therapeutics, and Bioelectronic Medicine

Industry leaders from United Therapeutics, IBM, the American College of Physicians, the FDA, and more convene for the seventh annual exploration of health care's evolving landscape

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--The future of health care is being rewritten right now. Artificial intelligence (AI), digital therapeutics and game-changing innovations such as bioelectronic medicine and vagus nerve stimulation are ushering in a new era of transformative possibilities. Northwell Health’s Constellation Forum returns for its seventh year, exploring the rapidly evolving health care landscape. This leading innovation summit brings together health care visionaries, investors and disruptors for a day of discussion and collaboration. Join us virtually or in-person in New York City on October 17, 2024, starting at 9 a.m. ET. Register at www.ConstellationForum.com.

Hosted by Michael J. Dowling, Northwell’s president and CEO, the forum titled “Navigating the New Healthcare Frontier,” will delve into the most pressing challenges and opportunities facing the industry today.

“Collaboration is key to advancing health care. By embracing new technologies and prioritizing patient well-being, we can drive meaningful change,” said Dowling, “For over seven years, the Forum has served as a catalyst for impactful dialogue, collaboration and propelling innovation.”

Attendees will gain insights from world-renowned experts on how these emerging technologies are reshaping health care delivery, patient care and the very definition of health itself, including:

  • Andrea Califano, PhD, president, CZ Biohub New York, Chan Zuckerberg Initiative
  • Douglas Kelly, MD, deputy center director for science, chief scientist, Center for Devices & Radiological Health (CDRH), Food and Drug Administration (FDA)
  • Arvind Krishna, chairman and CEO, IBM
  • Geoff Ling, MD, PhD, CEO, Ling and Associates, LLC, and former founding director of the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA)
  • Darilyn V. Moyer, MD, executive vice president and CEO, American College of Physicians
  • Shola Oyewole, senior vice president, Innovative Technology, United Therapeutics
  • Murthy Simhambhatla, PhD, president and CEO, SetPoint Medical
  • Craig Venter, PhD, founder, J. Craig Venter Institute

Bioelectronic medicine takes center stage at this year's forum. This rapidly emerging field, pioneered at Northwell's Feinstein Institutes for Medical Research under the leadership of Kevin J. Tracey, MD, explores the use of electrical stimulation and devices to treat inflammatory diseases. Experts believe bioelectronic medicine could revolutionize health care within the next year, offering targeted, non-pharmacological treatments with fewer side effects. Murthy Simhambhatla, president and CEO of SetPoint Medical, will join a panel exploring the future of bioelectronic medicine. His company’s vagus nerve stimulation device for rheumatoid arthritis has received Food and Drug Administration breakthrough designation and awaits clinical trial results.

For more information about the program and its speakers and to register your attendance, please visit: www.constellationforum.com.

About Northwell Health
Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals, about 900 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 87,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Contacts

Matthew Libassi
631-793-5325
mlibassi@northwell.edu

Northwell Health


Release Versions

Contacts

Matthew Libassi
631-793-5325
mlibassi@northwell.edu

More News From Northwell Health

Four Feinstein Institutes Scientists Honored as National Academy of Inventors Senior Members

MANHASSET, N.Y.--(BUSINESS WIRE)--In recognition of their impact on society through the successful production, patenting and commercialization of groundbreaking technologies, four esteemed scientists from Northwell Health’s Feinstein Institutes for Medical Research – Lior Brimberg, PhD; Jared M. Huston, MD; Stavros Zanos, MD, PhD; and Theodoros Zanos, PhD – have been named to the prestigious 2026 class of Senior Members by the National Academy of Inventors (NAI). This significant recognition hi...

Feinstein Institutes’ Scientists Discover Brain Circuit That Links Inflammation and Stress Response

MANHASSET, N.Y.--(BUSINESS WIRE)--What if there was a switch in the brain that could turn on or off the body’s physical response to stress? New research from scientists at Northwell Health's Feinstein Institutes for Medical Research has identified a specific brain circuit that acts as a control center for both inflammation and stress responses. Published today in the Journal of Experimental Medicine, the study shows that a specific group of brain cells are capable of controlling inflammation an...

Northwell’s AI-Powered iNav Speeds Pancreatic Cancer Detection and Care, New Study Shows

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Pancreatic cancer is notoriously difficult to identify, with more than 80 percent of patients diagnosed at an advanced stage, severely limiting treatment options. However, iNav, Northwell Health’s in-house artificial intelligence (AI) clinical tool, has shown the ability to cut the time from biopsy to diagnosis in half and accelerate treatment timelines for patients, according to a study published in The Oncologist. iNav, a machine learning-based natural la...
Back to Newsroom